Beacon Clinical Research Competitors and Similar CompaniesClear all

Beacon Clinical Research's competitors and similar companies include Galenos Research, Parexel International, Medpace and Accellacare UK.

	Beacon Clinical Research Beacon Clinical Research is a multi-specialty clinical research facility specializing in phase I-IV clinical trials.	Galenos Research Galenos Research is a clinical research company that conducts phase II-IV human clinical trials for the biopharmaceutical industry.	Parexel International Parexel International (MA) is a clinical research organization.	Medpace Medpace is a clinical contract research organization (CRO).	Accellacare UK Accellacare UK (formerly known as MeDiNova Research) is a clinical research company that provides clinical trial services.
Founding Date	Founding Date 2000	Founding Date 2007	Founding Date 1982	Founding Date 1992	Founding Date 1997
Type	Type Private	Type Private	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech clinical research pharma	Tags Healthcare biotech clinical research pharma	Tags Healthcare biotech clinical research pharma	Tags Healthcare biotech clinical research pharma	Tags Healthcare biotech clinical research pharma
Locations	Locations Quincy, US HQ	Locations Dallas, US HQ	Locations Newton, US HQ Olivos, AR Vicente López, AR Brisbane, AU Macquarie Park, AU Wavre, BE Sao Paulo, BR see more	Locations Cincinnati, US HQ Buenos Aires, AR South Yarra, AU Leuven, BE Leuven, BE Sao Paulo, BR Toronto, CA see more	Locations Coventry, GB HQ
Employees	Employees 12	Employees 4	Employees 20,806	Employees 5,90013% increase	Employees 2433% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $2.5b (FY, 2025)	Revenue (est.) £9.4m (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $1.8b (FY, 2025)	Cost of goods £1.6m (FY, 2021)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $760.6m (FY, 2025)	Gross profit £7.8m (FY, 2021)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income $451.1m (FY, 2025)	Net income £742.9k (FY, 2021)
Operating ⚠
Backlog	Backlog N/A	Backlog N/A	Backlog $4b (FY, 2017)	Backlog $2.7b (Q3, 2023)	Backlog N/A
Countries	Countries N/A	Countries N/A	Countries 52 (FY, 2017)	Countries 40 (Q3, 2023)	Countries 55 (Apr, 2023)